Our syndicated research services supply global market intelligence across a broad range of disease areas, quickly and cost-effectively
We are committed to providing accurate, ongoing market information using innovative, up-to-the-minute market research techniques to the pharma industry.
Therapy Watch: our real-time patient tracking tool provides instant access to the very latest market data including market shares, switch patterns, treatment patterns and patient demographics.
Living With: our series of patient reports offering in-depth insight into the patient journey from pre-diagnosis to stabilisation. These reports are based on quantitative market research studies conducted amongst large samples of patients living with specific chronic illnesses.
Sharing our knowledge
We offer complimentary workshops on the patient journey referencing our Living With and Therapy Watch data. Workshops are held in your offices at a date and time to suit you and the agenda can be tailored to meet your requirements.
We run a series of webinars referencing findings from our syndicated research.
Visit Rapport to download a recording of past webinars and find out about forthcoming events.
- Some example case studiesShifting perceptions of the use of probiotics in IBS Management
The challengeOur client was planning to launch an over-the-counter (OTC) probiotics product for the purposes of improving IBS management and wanted to understand current perceptions, practices and usage amoungst a range of healthcare professionals in emerging markets. They wanted to uncover potential leverage points to build a strong storyline and communication strategy for their product, which would encourage healthcare professionals to recommend its use to…read more »Understanding the patient journey and addiction treatment pathways
The challengeOur client had previously conducted some research and knew that a large proportion of target patients also had addiction issues. They wanted to know more about addiction treatment pathways and the issues that this large proportion of their customers and potential HCP treaters were facing. Therefore, they were seeking further insights to gain a 360 degree understanding to better serve their customers needs. …read more »Qualitative research with payers in low and middle income countries
The challenge Our client wanted to understand in detail the usage decision drivers, triggers and processes for a high-cost innovative Acute Heart Failure (AHF) drug used in the acute emergency setting in low and middle income countries where patients self-pay for healthcare. They also wanted to obtain a deep understanding of the groups of patients for whom self-pay is an issue and the sources of…read more »
- Our latest webinarsImmuno-oncology's evolution: Implications for pharma market researchers
In association with PMGroupread more »Webinar: Understanding Patient Willingness to Pay
What steps should pharma and medical device companies take to ensure they get their pricing strategy right in self-pay markets? A key feature of emerging markets is that patients often have to self-fund a high proportion of their healthcare costs. While private health insurance coverage is increasing in many emerging markets, penetration typically remains low, even among middle to high income segments of the population.…read more »Webinar: Ensuring an Actionable Segmentation
A segmentation study comes with high visibility and high stakes across your marketing and sales organisations. Ensuring that a segmentation is actionable is a consistent issue, particularly when stakeholders with multiple interests are involved. Download our latest webcast in which our quantitative experts Tom Nolte and Dr Marianne Jaeger will utilise knowledge and experience garnered from more than 25 years of conducting global segmentations, to explore…read more »